Sharpless Calls For A Nimble, Flexible, More Efficient US FDA

03 May 2019

In his first speech to an outside group, Sharpless strikes a collaborative tone, saying he expects to listen to the advice of the FDA bar, as well as his own experts.

FDA acting Commissioner Ned Sharpless speaking at FDLI 2019 — Acting FDA Commissioner Norman Sharpless reiterated during a speech to the Food and Drug Law Institute annual conference that he does not intend to slow the agency's progress in recent years. • Source: Ferdous Al-Faruque

Sharpless Calls For A Nimble, Flexible, More Efficient US FDA

More from US FDA

More from Agency Leadership